Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
Paclitaxel is a successful anti-cancer drug that kills cancer cells in two-dimensional culture through perturbation of mitosis, but whether it causes tumour regression by anti-mitotic actions is controversial. Drug candidates that specifically target mitosis, including inhibitors of kinesin-5, AurkA...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
The Royal Society
2017-01-01
|
| Series: | Open Biology |
| Assuntos: | |
| Acceso en liña: | https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.170182 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|